Showing results (1021-1030 of 2,915) with videos related to

Sort By:
Pageof 292
Cancer Gene Therapy|June 1, 2000
Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapyM Hoshi, A Harada, T Kawase, et al.
Cancer Gene Therapy|June 1, 2000
Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapyS Steffens, S Frank, U Fischer, et al.
Cancer Gene Therapy|May 16, 2000
The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapyN J Thatcher, R J Edwards, N R Lemoine, et al.
Cancer Gene Therapy|May 16, 2000
Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptorsL Alvarez-Vallina, R Yañez, B Blanco, et al.
Cancer Gene Therapy|May 16, 2000
Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cellsY Horio, Y Hasegawa, Y Sekido, et al.
Cancer Gene Therapy|May 16, 2000
Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapyY Hasegawa, Y Nishiyama, K Imaizumi, et al.
Cancer Gene Therapy|April 15, 2000
Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinomaT Tsuchida, H Kijima, S Hori, et al.
Cancer Gene Therapy|April 15, 2000
Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 moleculesY Liu, H Wang, J Zhao, et al.
Cancer Gene Therapy|April 15, 2000
Construction and function of a recombinant adenovirus encoding a human aquaporin 1-green fluorescent protein fusion productA T Hoque, X Liu, H Kagami, et al.
Cancer Gene Therapy|April 19, 2000
Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor culturesA Cignetti, A Guarini, A Gillio Tos, et al.
Pageof 292